Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frederic Arnold

Showing results (1-10 of 22) with videos related to

Pageof 3
Sort By:
BMC Infectious Diseases|September 14, 2022
Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune diseaseFrederic Arnold, Daniela Huzly, Yakup Tanriver, et al.
Artificial Organs|May 1, 2022
Integration of sustained low-efficiency dialysis into extracorporeal membrane oxygenation circuit in critically ill COVID-19 patients: A feasibility studyFrederic Arnold, Rika Wobser, Johannes Kalbhenn, et al.
Journal of Internal Medicine|November 5, 2023
HbA1c-dependent projection of long-term renal outcomesFrederic Arnold, Julia Kappes, Felix A Rottmann, et al.
American Journal of Nephrology|February 26, 2025
Impact of Renin-Angiotensin-Aldosterone System Inhibition on Advanced Chronic Kidney Disease Progression: A Retrospective Observational StudyLukas Westermann, Janis M Nolde, Johannes Wiegel, et al.
Clinical Transplantation|April 3, 2022
IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control studyUrsula Tanriver, Florian Emmerich, Jonas Florian Hummel, et al.
World Journal of Clinical Cases|December 14, 2019
Recuperation of severe tumoral calcinosis in a dialysis patient: A case reportLukas Westermann, Lisa K Isbell, Marie K Breitenfeldt, et al.
BMC Nephrology|September 3, 2023
Correction to: Clinical covariates influencing clinical outcomes in primary membranous nephropathyLukas Westermann, Felix A Rottmann, Martin J Hug, et al.
BMC Nephrology|January 11, 2023
Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective studyThomas Welte, Frederic Arnold, Lukas Westermann, et al.
BMC Nephrology|January 14, 2018
Treating C3 glomerulopathy with eculizumabThomas Welte, Frederic Arnold, Julia Kappes, et al.
BMC Nephrology|August 10, 2023
Clinical covariates influencing clinical outcomes in primary membranous nephropathyLukas Westermann, Felix A Rottmann, Martin J Hug, et al.
Pageof 3

Showing results (1-10 of 22) with videos related to

Sort By:
Pageof 3
BMC Infectious Diseases|September 14, 2022
Response to SARS-CoV-2 vaccines in patients receiving B-cell modulating antibodies for renal autoimmune diseaseFrederic Arnold, Daniela Huzly, Yakup Tanriver, et al.
Artificial Organs|May 1, 2022
Integration of sustained low-efficiency dialysis into extracorporeal membrane oxygenation circuit in critically ill COVID-19 patients: A feasibility studyFrederic Arnold, Rika Wobser, Johannes Kalbhenn, et al.
Journal of Internal Medicine|November 5, 2023
HbA1c-dependent projection of long-term renal outcomesFrederic Arnold, Julia Kappes, Felix A Rottmann, et al.
American Journal of Nephrology|February 26, 2025
Impact of Renin-Angiotensin-Aldosterone System Inhibition on Advanced Chronic Kidney Disease Progression: A Retrospective Observational StudyLukas Westermann, Janis M Nolde, Johannes Wiegel, et al.
Clinical Transplantation|April 3, 2022
IFNL4 rs368234815 polymorphism does not predict risk of BK virus associated nephropathy after living-donor kidney transplant: A case-control studyUrsula Tanriver, Florian Emmerich, Jonas Florian Hummel, et al.
World Journal of Clinical Cases|December 14, 2019
Recuperation of severe tumoral calcinosis in a dialysis patient: A case reportLukas Westermann, Lisa K Isbell, Marie K Breitenfeldt, et al.
BMC Nephrology|September 3, 2023
Correction to: Clinical covariates influencing clinical outcomes in primary membranous nephropathyLukas Westermann, Felix A Rottmann, Martin J Hug, et al.
BMC Nephrology|January 11, 2023
Eculizumab as a treatment for C3 glomerulopathy: a single-center retrospective studyThomas Welte, Frederic Arnold, Lukas Westermann, et al.
BMC Nephrology|January 14, 2018
Treating C3 glomerulopathy with eculizumabThomas Welte, Frederic Arnold, Julia Kappes, et al.
BMC Nephrology|August 10, 2023
Clinical covariates influencing clinical outcomes in primary membranous nephropathyLukas Westermann, Felix A Rottmann, Martin J Hug, et al.
Pageof 3